Novel diagnostic platform using cell-free mRNA to diagnose neuro-degenerative and other diseases.
Founder(s)
Dr. Stephen Quake, Scripps Institute
THEME(S)
Emerging therapeutic platforms
SECTOR(S)
Healthcare
Investment Stage
Early
Company Status
Private